vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and WillScot Holdings Corp (WSC). Click either name above to swap in a different company.
WillScot Holdings Corp is the larger business by last-quarter revenue ($566.0M vs $493.8M, roughly 1.1× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -33.1%, a 39.9% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -6.1%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -1.8%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
WillScot Holdings Corp is a leading provider of modular space solutions and portable storage services across North America. It serves a wide range of sectors including construction, commercial development, education, healthcare, government projects, and special events, offering flexible, scalable temporary and semi-permanent space solutions tailored to diverse client needs.
MD vs WSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $566.0M |
| Net Profit | $33.7M | $-187.3M |
| Gross Margin | — | 50.4% |
| Operating Margin | 9.9% | -32.5% |
| Net Margin | 6.8% | -33.1% |
| Revenue YoY | -1.7% | -6.1% |
| Net Profit YoY | 10.5% | -310.0% |
| EPS (diluted) | $0.40 | $-1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $566.0M | ||
| Q3 25 | $492.9M | $566.8M | ||
| Q2 25 | $468.8M | $589.1M | ||
| Q1 25 | $458.4M | $559.6M | ||
| Q4 24 | $502.4M | $602.5M | ||
| Q3 24 | $511.2M | $601.4M | ||
| Q2 24 | $504.3M | $604.6M | ||
| Q1 24 | $495.1M | $587.2M |
| Q4 25 | $33.7M | $-187.3M | ||
| Q3 25 | $71.7M | $43.3M | ||
| Q2 25 | $39.3M | $47.9M | ||
| Q1 25 | $20.7M | $43.1M | ||
| Q4 24 | $30.5M | $89.2M | ||
| Q3 24 | $19.4M | $-70.5M | ||
| Q2 24 | $-153.0M | $-46.9M | ||
| Q1 24 | $4.0M | $56.2M |
| Q4 25 | — | 50.4% | ||
| Q3 25 | — | 49.7% | ||
| Q2 25 | — | 50.3% | ||
| Q1 25 | — | 53.7% | ||
| Q4 24 | — | 55.8% | ||
| Q3 24 | — | 53.5% | ||
| Q2 24 | — | 54.1% | ||
| Q1 24 | — | 54.0% |
| Q4 25 | 9.9% | -32.5% | ||
| Q3 25 | 13.8% | 21.0% | ||
| Q2 25 | 12.8% | 21.5% | ||
| Q1 25 | 7.0% | 21.3% | ||
| Q4 24 | 7.8% | 28.9% | ||
| Q3 24 | 6.6% | -5.9% | ||
| Q2 24 | -31.3% | -0.9% | ||
| Q1 24 | 3.2% | 22.1% |
| Q4 25 | 6.8% | -33.1% | ||
| Q3 25 | 14.5% | 7.6% | ||
| Q2 25 | 8.4% | 8.1% | ||
| Q1 25 | 4.5% | 7.7% | ||
| Q4 24 | 6.1% | 14.8% | ||
| Q3 24 | 3.8% | -11.7% | ||
| Q2 24 | -30.3% | -7.7% | ||
| Q1 24 | 0.8% | 9.6% |
| Q4 25 | $0.40 | $-1.02 | ||
| Q3 25 | $0.84 | $0.24 | ||
| Q2 25 | $0.46 | $0.26 | ||
| Q1 25 | $0.24 | $0.23 | ||
| Q4 24 | $0.37 | $0.48 | ||
| Q3 24 | $0.23 | $-0.37 | ||
| Q2 24 | $-1.84 | $-0.25 | ||
| Q1 24 | $0.05 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $14.6M |
| Total DebtLower is stronger | $570.5M | $3.6B |
| Stockholders' EquityBook value | $865.9M | $856.3M |
| Total Assets | $2.2B | $5.8B |
| Debt / EquityLower = less leverage | 0.66× | 4.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $14.6M | ||
| Q3 25 | $340.1M | $14.8M | ||
| Q2 25 | $224.7M | $12.8M | ||
| Q1 25 | $99.0M | $10.7M | ||
| Q4 24 | $229.9M | $9.0M | ||
| Q3 24 | $103.8M | $11.0M | ||
| Q2 24 | $19.4M | $5.9M | ||
| Q1 24 | $8.0M | $13.1M |
| Q4 25 | $570.5M | $3.6B | ||
| Q3 25 | $577.2M | $3.6B | ||
| Q2 25 | $583.9M | $3.7B | ||
| Q1 25 | $590.5M | $3.6B | ||
| Q4 24 | $597.1M | $3.7B | ||
| Q3 24 | — | $3.6B | ||
| Q2 24 | — | $3.5B | ||
| Q1 24 | — | $3.5B |
| Q4 25 | $865.9M | $856.3M | ||
| Q3 25 | $890.7M | $1.1B | ||
| Q2 25 | $833.8M | $1.0B | ||
| Q1 25 | $789.2M | $1.0B | ||
| Q4 24 | $764.9M | $1.0B | ||
| Q3 24 | $732.5M | $1.1B | ||
| Q2 24 | $706.5M | $1.2B | ||
| Q1 24 | $856.2M | $1.3B |
| Q4 25 | $2.2B | $5.8B | ||
| Q3 25 | $2.2B | $6.1B | ||
| Q2 25 | $2.1B | $6.1B | ||
| Q1 25 | $2.0B | $6.0B | ||
| Q4 24 | $2.2B | $6.0B | ||
| Q3 24 | $2.1B | $6.0B | ||
| Q2 24 | $2.0B | $6.0B | ||
| Q1 24 | $2.2B | $6.2B |
| Q4 25 | 0.66× | 4.15× | ||
| Q3 25 | 0.65× | 3.39× | ||
| Q2 25 | 0.70× | 3.55× | ||
| Q1 25 | 0.75× | 3.56× | ||
| Q4 24 | 0.78× | 3.62× | ||
| Q3 24 | — | 3.42× | ||
| Q2 24 | — | 2.88× | ||
| Q1 24 | — | 2.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $158.9M |
| Free Cash FlowOCF − Capex | — | $149.7M |
| FCF MarginFCF / Revenue | — | 26.5% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $737.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $158.9M | ||
| Q3 25 | $137.3M | $191.2M | ||
| Q2 25 | $137.2M | $205.3M | ||
| Q1 25 | $-117.5M | $206.6M | ||
| Q4 24 | $133.0M | $178.9M | ||
| Q3 24 | $91.8M | $-1.6M | ||
| Q2 24 | $107.0M | $175.6M | ||
| Q1 24 | $-125.2M | $208.7M |
| Q4 25 | — | $149.7M | ||
| Q3 25 | — | $186.9M | ||
| Q2 25 | — | $199.0M | ||
| Q1 25 | — | $202.0M | ||
| Q4 24 | — | $176.6M | ||
| Q3 24 | — | $-4.9M | ||
| Q2 24 | — | $169.4M | ||
| Q1 24 | — | $202.1M |
| Q4 25 | — | 26.5% | ||
| Q3 25 | — | 33.0% | ||
| Q2 25 | — | 33.8% | ||
| Q1 25 | — | 36.1% | ||
| Q4 24 | — | 29.3% | ||
| Q3 24 | — | -0.8% | ||
| Q2 24 | — | 28.0% | ||
| Q1 24 | — | 34.4% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 4.41× | ||
| Q2 25 | 3.49× | 4.28× | ||
| Q1 25 | -5.66× | 4.80× | ||
| Q4 24 | 4.36× | 2.01× | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | 3.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
WSC
| Modular Space Leasing | $249.8M | 44% |
| Value Added Product And Services | $101.0M | 18% |
| Portable Storage Leasing | $83.0M | 15% |
| Delivery Revenue | $48.2M | 9% |
| Installation Revenue | $45.0M | 8% |
| Rental Units | $19.7M | 3% |
| New Units | $15.5M | 3% |
| Value Added Services | $10.3M | 2% |
| Other Leasing Related Products And Services | $3.8M | 1% |
